Literature DB >> 20626741

IL1RN VNTR and IL2-330 polymorphic genes are independently associated with chronic immune thrombocytopenia.

Andreia Maria Camargos Rocha1, Cláudia De Souza, Gifone Aguiar Rocha, Fabrício Freire De Melo, Isadora Sofia Borges Saraiva, Nelma Cristina Diogo Clementino, Marília Campos Abreu Marino, Dulciene Maria Magalhães Queiroz.   

Abstract

Chronic Immune Thrombocytopenia (cITP) is an acquired immune-mediated disease associated with a T-helper cell type 1 (Th1) immune polarization, whose genetic risk factors, however, are largely unknown. We investigated polymorphisms in promoter regions of genes that code molecules involved in proinflammatory immune response [IL1B-31T/C, IL1RN variable number tandem repeats (VNTR), IL2-330T/G, and TNF-307G/A] as well as in genes that code Toll like receptors (TLR) (TLR2 Arg753Gln, TLR4 Asp299Gly and TLR5 Arg(392stop)) in 122 patients with cITP and 541 blood donors. The frequencies of the IL1RN polymorphic allele 2 (P = 0·001) and of the IL2-330 polymorphic allele G (P =0·004) were significantly higher in cITP patients than in blood donors. In logistic analysis adjusting for age and gender, the polymorphisms remained independently associated with cITP. Enhanced serum concentrations of interleukin (IL)-1α and IL-1β were observed in cITP (P < 10(-3) ) and blood donor (P = 0·04) carriers of the IL1RN*2. Also, the serum levels of IL-2 and γ-interferon (IFN-γ) were increased in cITP patients (P < 10(-3) and P = 0·04 respectively) and blood donors (P < 10(-3) and P = 0·03 respectively) harbouring the IL2-330G allele. Here we demonstrated that IL2-330G and IL1RN*2 are independently associated with cITP and are functional in vivo, which strongly suggests that they contribute to the pathogenesis of cITP.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20626741     DOI: 10.1111/j.1365-2141.2010.08318.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia.

Authors:  Hui Zhong; James Bussel; Karina Yazdanbakhsh
Journal:  Br J Haematol       Date:  2014-09-24       Impact factor: 6.998

2.  The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia.

Authors:  Andreia Maria Camargos Rocha; Cláudia Souza; Gifone Aguiar Rocha; Fabrício Freire de Melo; Nelma Cristina Diogo Clementino; Marília Campos Abreu Marino; Adriana Bozzi; Maria Luiza Silva; Olindo Assis Martins Filho; Dulciene Maria Magalhães Queiroz
Journal:  Haematologica       Date:  2011-10       Impact factor: 9.941

3.  Stroke, IL-1ra, IL1RN, infection and outcome.

Authors:  Kyra J Becker; Dorender Dankwa; Richard Lee; Juliane Schulze; Dannielle Zierath; Patricia Tanzi; Kevin Cain; Alexander Dressel; Dean Shibata; Jonathan Weinstein
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

4.  Toll-Like Receptor 9 (TLR9) Gene C/T (rs352140) Polymorphisms in Adult Primary Immune Thrombocytopenia.

Authors:  Alaa Efat Hassan; Sabry Shoeib; Esaam Abdelmohsen; Aida Nazir; Ashraf Dawood; Heba Gamal; Mohamed Abdelhafez
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

5.  Sialic acid and platelet count regulation: Implications in immune thrombocytopenia.

Authors:  Melissa M Lee-Sundlov; Leonardo Rivadeneyra; Hervé Falet; Karin M Hoffmeister
Journal:  Res Pract Thromb Haemost       Date:  2022-04-08

6.  Association of CD40 gene polymorphisms and immune thrombocytopenic purpura in the adult Egyptian population.

Authors:  Hend Nabil Ellithy; Sherif Mohamed Yousry; Asmaa Abdel-Aal; Lelian Tawadros; Nouran Momen
Journal:  Blood Res       Date:  2022-08-03

7.  The serum levels of the cytokines involved in the Th17 and Th1 cell commitment are increased in individuals with borderline thrombocytopenia.

Authors:  Andreia Maria Camargos Rocha; Cláudia Souza; Gifone Aguiar Rocha; Fabrício Freire de Melo; Nelma Cristina Diogo Clementino; Marília Campos Abreu Marino; Dulciene Maria Magalhães Queiroz
Journal:  J Hematol Oncol       Date:  2013-04-12       Impact factor: 17.388

8.  Interleukin-1B (IL-1B-31 and IL-1B-511) and interleukin-1 receptor antagonist (IL-1Ra) gene polymorphisms in primary immune thrombocytopenia.

Authors:  Deependra Kumar Yadav; Anil Kumar Tripathi; Divya Gupta; Saurabh Shukla; Aloukick Kumar Singh; Ashutosh Kumar; Jyotsna Agarwal; K N Prasad
Journal:  Blood Res       Date:  2017-12-26

Review 9.  Emerging Concepts in Immune Thrombocytopenia.

Authors:  Maurice Swinkels; Maaike Rijkers; Jan Voorberg; Gestur Vidarsson; Frank W G Leebeek; A J Gerard Jansen
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.